Desipramine hydrochloride 100 MG Oral Tablet — RxCUI 1099292
RxNorm drug concept · Semantic clinical drug
RxCUI 1099292
Semantic clinical drug · SCD
● Current RxNorm concept 47 FDA products
78 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1099292
Official nameDesipramine hydrochloride 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdesipramine HCl 100 MG Oral Tablet
FDA products mapped47
Package NDCs mapped78
Reported Medicaid activity (SDUD)5,105 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Desipramine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Desipramine is prescribed to treat depression. It's been around for decades and belongs to a group of older antidepressants called tricyclics. Brands you might see include Norprami...
- Some people notice small improvements within 2 to 5 days, but for most people the full benefit takes about 2 to 3 weeks. It's important not to stop taking it early just because you...
- How long does it take before I start feeling better?
- Common side effects include dry mouth, drowsiness, dizziness, constipation, and blurred vision — these often ease as your body adjusts. Call your doctor right away if you notice ch...
🕸️ Concept Web — How Desipramine hydrochloride 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Desipramine hydrochloride 100 MG Oral Tablet
RxCUI 1099292 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Desipramine
3247IN -
Desipramine hydrochloride
203174PIN
-
Desipramine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Norpramin
203771BN
-
Norpramin
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Desipramine Oral Tablet
371709SCDF -
Desipramine hydrochloride Oral Tablet
2648712SCDFP -
Desipramine Oral Product
1153953SCDG -
Desipramine Pill
1153954SCDG -
Desipramine hydrochloride Oral Product
2663531SCDGP -
Desipramine hydrochloride Pill
2662926SCDGP -
Desipramine Oral Tablet [Norpramin]
369482SBDF -
Desipramine hydrochloride Oral Tablet [Norpramin]
2655221SBDFP - +5 more in this family
-
Desipramine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Desipramine hydrochloride 100 MG
1099291SCDC -
Desipramine hydrochloride 100 MG Oral Tablet [Norpramin]
1099294SBD -
Desipramine hydrochloride 100 MG [Norpramin]
1099293SBDC
-
Desipramine hydrochloride 100 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Desipramine hydrochloride 100 MG
SCDC · 1099291 -
Desipramine Oral Tablet
SCDF · 371709 -
Desipramine hydrochloride Oral Tablet
SCDFP · 2648712 -
Desipramine Oral Product
SCDG · 1153953 -
Desipramine Pill
SCDG · 1153954 -
Desipramine hydrochloride Oral Product
SCDGP · 2663531 -
Desipramine hydrochloride Pill
SCDGP · 2662926
Brand-Name Concepts
-
Desipramine hydrochloride 100 MG Oral Tablet [Norpramin]
SBD · 1099294 -
Desipramine hydrochloride 100 MG [Norpramin]
SBDC · 1099293 -
Desipramine Oral Tablet [Norpramin]
SBDF · 369482 -
Desipramine hydrochloride Oral Tablet [Norpramin]
SBDFP · 2655221 -
Norpramin Oral Product
SBDG · 1185720 -
Norpramin Pill
SBDG · 1185721 -
Norpramin
BN · 203771
📦 FDA Products & Package NDCs
47 products · 78 package NDCs
78 package NDCs map to RxCUI 1099292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 23155-0578-01 | 100 TABLET in 1 BOTTLE (23155-578-01) | DESIPRAMINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-11-01 |
| 23155-0579-01 | 100 TABLET in 1 BOTTLE (23155-579-01) | DESIPRAMINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-11-01 |
| 23155-0580-01 | 100 TABLET in 1 BOTTLE (23155-580-01) | DESIPRAMINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-11-01 |
| 23155-0581-01 | 100 TABLET in 1 BOTTLE (23155-581-01) | DESIPRAMINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-11-01 |
| 23155-0582-01 | 100 TABLET in 1 BOTTLE (23155-582-01) | DESIPRAMINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-11-01 |
| 30698-0007-01 | 100 TABLET, SUGAR COATED in 1 BOTTLE (30698-007-01) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 30698-0011-01 | 100 TABLET, SUGAR COATED in 1 BOTTLE (30698-011-01) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 30698-0015-01 | 100 TABLET, SUGAR COATED in 1 BOTTLE (30698-015-01) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 30698-0019-01 | 100 TABLET, SUGAR COATED in 1 BOTTLE (30698-019-01) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 30698-0020-01 | 100 TABLET, SUGAR COATED in 1 BOTTLE (30698-020-01) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 30698-0021-50 | 50 TABLET, SUGAR COATED in 1 BOTTLE (30698-021-50) | Norpramin | Validus Pharmaceuticals LLC | 1964-11-20 |
| 45963-0341-02 | 100 TABLET, FILM COATED in 1 BOTTLE (45963-341-02) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-05-09 |
| 45963-0342-02 | 100 TABLET, FILM COATED in 1 BOTTLE (45963-342-02) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-05-01 |
| 45963-0343-02 | 100 TABLET, FILM COATED in 1 BOTTLE (45963-343-02) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-06-04 |
| 45963-0344-02 | 100 TABLET, FILM COATED in 1 BOTTLE (45963-344-02) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-05-08 |
| 45963-0345-02 | 100 TABLET, FILM COATED in 1 BOTTLE (45963-345-02) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-07-19 |
| 45963-0346-50 | 50 TABLET, FILM COATED in 1 BOTTLE (45963-346-50) | Desipramine Hydrochloride | Actavis Pharma, Inc. | 2006-05-09 |
| 46708-0315-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-315-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0315-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-315-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0315-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-315-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0316-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-316-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0316-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-316-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0316-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-316-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0317-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-317-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0317-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-317-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0317-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-317-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0318-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-318-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0318-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-318-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0318-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-318-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0319-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-319-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0319-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-319-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0319-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-319-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0320-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-320-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0320-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-320-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0320-50 | 50 TABLET, FILM COATED in 1 BOTTLE (46708-320-50) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 46708-0320-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-320-91) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2021-07-08 |
| 50742-0112-01 | 100 TABLET in 1 BOTTLE (50742-112-01) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 50742-0113-01 | 100 TABLET in 1 BOTTLE (50742-113-01) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 50742-0114-01 | 100 TABLET in 1 BOTTLE (50742-114-01) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 50742-0115-01 | 100 TABLET in 1 BOTTLE (50742-115-01) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 50742-0116-01 | 100 TABLET in 1 BOTTLE (50742-116-01) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 50742-0117-50 | 50 TABLET in 1 BOTTLE (50742-117-50) | DESIPRAMINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 2018-09-19 |
| 62135-0593-12 | 120 TABLET in 1 BOTTLE (62135-593-12) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62135-0594-12 | 120 TABLET in 1 BOTTLE (62135-594-12) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62135-0595-12 | 120 TABLET in 1 BOTTLE (62135-595-12) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62135-0597-12 | 120 TABLET in 1 BOTTLE (62135-597-12) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62135-0598-30 | 30 TABLET in 1 BOTTLE (62135-598-30) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62135-0599-30 | 30 TABLET in 1 BOTTLE (62135-599-30) | Desipramine Hydrochloride | Chartwell RX, LLC | 2023-05-12 |
| 62332-0315-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-315-30) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2021-07-08 |
| 62332-0315-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-315-31) | DESIPRAMINE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2021-07-08 |
Observed labelers:
Alembic Pharmaceuticals Inc. (19) ·
Alembic Pharmaceuticals Limited (19) ·
Amneal Pharmaceuticals NY LLC (11) ·
Actavis Pharma, Inc. (6) ·
Chartwell RX, LLC (6) ·
Ingenus Pharmaceuticals, LLC (6)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.